4Tallman MS.Gurative strategies in acute promyelocytic leukaemia[M].WashingtonDC:Hematology 2003 American Society of Hematology Education Program Book,2003,90-101. 被引量：1
5Wong ZY.Treatment of acute leukaemia by inducing differentiation and apotptosis[M].Washington DC:Hematology 2003 Ameeican Society of Hematology Education Program Book, 2003,1-13. 被引量：1
6Douer D.New advances in the treatment of acute promyelocytic leukaemia[J].Int J Hematol,2003,76(Suppl 2):178. 被引量：1
3[1]Yamane T, Hino M, Ohta K, et al. Allogeneic peripheral blood stem cell transplantation. Rinsho Byori, 1999, 110(Suppl) :85. 被引量：1
4[2]Takenaka K, Harada M. Nationwide survey of allogeneic pe ripheral blood stem cell transplantation in Japan. Rinsho Ketsue ki, 1999, 40 (6) :451. 被引量：1
5[3]Harada M. Allogeneic peripheral blood stem cell transplantation as an alternative to allogeneic bone marrow transplanta tion. Intern Med, 1998, 37 (12) :1001. 被引量：1
6[4]Lebel- Medeiros N J, Fitz P A. Rationale, process, and nu tritional implications of peripheral blood stem cell transplanta tion. J Am Diet Assoc, 1998, 98 (9) : 1024. 被引量：1
7[5]Kiss J E, Rybka W B, Winkelstein A, et al. Relationship of CD+34 cell dose to early and late hematopoiesis following autolo gous peripheral blood stem cell transplantation. Bone Marrow Transplant, 1997, 19 (4) :303. 被引量：1
8[6]Sugio Y, Tokunaga Y, Nomura A, et al. Peripheral blood stem cell transplantation-practices of mobilization and har vest. Rinsho Byori, 1999, 110 (Suppl) :63. 被引量：1
9[7]Schiflman K, Buckner C D, Maziarz R, et al. High-dose busulfan, melphalan, and thiotepa followed by autologous pe ripheral blood stem cell transplantation in patients with aggres sive lymphoma or relapsed Hodgkin's disease. Biol Blood Mar row Transplant, 1997, 3 (5) :261. 被引量：1
10[8]Collby C, McAfee S L, Finkelstein D M, et al. Early vs de layed administration of G-CSF following autologous peripheral blood stem cell transplantation. Bone Marrow Transplant, 1998,21 (10) :1005. 被引量：1
